Kevin Schutz Email

Director . Adimab

Current Roles

Employees:
166
Revenue:
$32.2M
About
Adimab's yeast-based discovery platform functions as a synthetic human immune system to create novel antibody therapeutics across an extensive range of diseases, including cancer as well as autoimmune and infectious diseases. We are a profitable privately-held biotech company, backed by top-tier venture capital firms including Google Ventures, OrbiMed Advisors, Polaris Partners, and SV Life Sciences. We are unique in our ability to take a long-term view on value creation which allows us to continuously refine and improve our technology and make substantial investments in R&D.
Adimab Address
7 Lucent Drive
Lebanon, NH
United States
Adimab Email

Past Companies

AdimabDirector
Adimab, LLCAssociate Director
Adimab, LLCGroup Leader

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.